Cefpodoxime and Clavulanic acid, which are both part of the cephalosporin and beta-lactamase inhibitor drug classes, are mixed in Monocef-O CV Dry Syrup. Those with mild to intermediate infections like ear infection, nose and throat infections, respiratory tract infections, urinary tract infections, reproductive tract infections, and skin infections are prevented with Monocef-O CV Dry Syrup.

Those who are sensitive to Cefpodoxime, Clavulanic Acid, or other members of the cephalosporin class should not use Monocef-O CV Dry Syrup. Galactose intolerance, lactose intolerance, and glucose-galactose malabsorption, conditions characterized by the body's inability to absorb glucose and galactose sugars, are also not suggested for use in patients.

Usage instructions-

• Use as directed by your doctor or read the pack carefully.

How it works-

Monocef-O CV Dry Syrup aids in the prevention of mild to moderate infections. Clavulanic acid works by lowering resistance to Cefpodoxime and enhancing its activity against bacterial infections, preventing infections in susceptible children. Cefpodoxime works by preventing the formation of the protective covering of the bacteria, which is necessary for the survival of bacteria.

Safety information-

PREGNANCY

It is recommended to consult your doctor before taking it during pregnancy.

BREASTFEEDING

Avoid this medication during breastfeeding or use it after consulting the doctor.

LIVER

If you have any concerns about using this medicine in patients with liver impairment, please consult your doctor.